An Ongoing Role of &agr;-Calcitonin Gene–Related Peptide as Part of a Protective Network Against Hypertension, Vascular Hypertrophy, and Oxidative Stress
暂无分享,去创建一个
A. Shah | L. Gnudi | R. Heads | P. de Winter | G. Pozsgai | S. Brain | R. King | X. Kodji | Sarah-Jane Smillie | A. Sams | R. Siow | Cecile Dessapt-Baradez | Emilie M. Outzen | E. Fernandes | N. Marshall | C. Dessapt-Baradez
[1] T. Koyama,et al. Endogenous CGRP protects against neointimal hyperplasia following wire-induced vascular injury. , 2013, Journal of molecular and cellular cardiology.
[2] D. DiPette,et al. Renal protective effects of α-calcitonin gene-related peptide in deoxycorticosterone-salt hypertension. , 2013, American journal of physiology. Renal physiology.
[3] L. Gnudi,et al. A Role for TRPV1 in Influencing the Onset of Cardiovascular Disease in Obesity , 2013, Hypertension.
[4] Min Zhang,et al. Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase , 2012, Circulation research.
[5] Wei-Hua Wu,et al. Inhibitory effect of calcitonin gene-related peptide on hypoxia-induced rat pulmonary artery smooth muscle cells proliferation: role of ERK1/2 and p27. , 2012, European journal of pharmacology.
[6] S. Brain,et al. Calcitonin gene-related peptide (CGRP) and its role in hypertension , 2011, Neuropeptides.
[7] D. Andersson,et al. 4-Oxo-2-nonenal (4-ONE): Evidence of Transient Receptor Potential Ankyrin 1-Dependent and -Independent Nociceptive and Vasoactive Responses In Vivo , 2011, Journal of Pharmacology and Experimental Therapeutics.
[8] Ting-ting Li,et al. Calcitonin gene-related peptide inhibits angiotensin II-induced endothelial progenitor cells senescence through up-regulation of klotho expression. , 2010, Atherosclerosis.
[9] F. Faraci,et al. Receptor Activity-Modifying Protein-1 Augments Cerebrovascular Responses to Calcitonin Gene-Related Peptide and Inhibits Angiotensin II-Induced Vascular Dysfunction , 2010, Stroke.
[10] A. Shah,et al. Oxidative Stress and Endothelial Dysfunction in Aortas of Aged Spontaneously Hypertensive Rats by NOX1/2 Is Reversed by NADPH Oxidase Inhibition , 2010, Hypertension.
[11] Dachun Yang,et al. Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension. , 2010, Cell metabolism.
[12] C. Lines,et al. Randomized, controlled trial of telcagepant over four migraine attacks , 2010, Cephalalgia : an international journal of headache.
[13] F. Abboud,et al. Receptor Activity–Modifying Protein 1 Increases Baroreflex Sensitivity and Attenuates Angiotensin-Induced Hypertension , 2010, Hypertension.
[14] O. Carretero,et al. Lack of Glutathione Peroxidase 1 Accelerates Cardiac-Specific Hypertrophy and Dysfunction in Angiotensin II Hypertension , 2010, Hypertension.
[15] A. Shah,et al. Protection of Angiotensin II–Induced Vascular Hypertrophy in Vascular Smooth Muscle–Targeted Receptor Activity-Modifying Protein 2 Transgenic Mice , 2009, Hypertension.
[16] D. Luo,et al. Calcitonin gene-related peptide-mediated antihypertensive and anti-platelet effects by rutaecarpine in spontaneously hypertensive rats , 2008, Peptides.
[17] A. Shepard,et al. Nox4 Oxidase Overexpression Specifically Decreases Endogenous Nox4 mRNA and Inhibits Angiotensin II–Induced Adventitial Myofibroblast Migration , 2008, Hypertension.
[18] A. Shah,et al. A reactive oxygen species-mediated component in neurogenic vasodilatation. , 2008, Cardiovascular research.
[19] F. Faraci,et al. Glutathione Peroxidase-1 Plays a Major Role in Protecting Against Angiotensin II–Induced Vascular Dysfunction , 2008, Hypertension.
[20] Ruiping Huang,et al. Deletion of the mouse alpha-calcitonin gene-related peptide gene increases the vulnerability of the heart to ischemia-reperfusion injury. , 2008, American journal of physiology. Heart and circulatory physiology.
[21] D. Stec,et al. HO-1 induction lowers blood pressure and superoxide production in the renal medulla of angiotensin II hypertensive mice. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.
[22] C. Somasundaram,et al. Adventitial Neuronal Somata , 2006, Journal of Vascular Research.
[23] K. Katki,et al. Role of Calcitonin Gene-Related Peptide in Hypertension-Induced Renal Damage , 2005, Hypertension.
[24] E. Pintér,et al. An examination of neurogenic mechanisms involved in mustard oil-induced inflammation in the mouse. , 2005, European journal of pharmacology.
[25] Donna H. Wang,et al. Development of angiotensin II-induced hypertension: role of CGRP and its receptor , 2005, Journal of hypertension.
[26] Xian Wang,et al. Intramuscular gene transfer of CGRP inhibits neointimal hyperplasia after balloon injury in the rat abdominal aorta. , 2004, American journal of physiology. Heart and circulatory physiology.
[27] L. Chau,et al. Heme Oxygenase-1 Inhibits Angiotensin II–Induced Cardiac Hypertrophy In Vitro and In Vivo , 2004, Circulation.
[28] S. Brain,et al. Vascular actions of calcitonin gene-related peptide and adrenomedullin. , 2004, Physiological reviews.
[29] D. Liao,et al. Effect of calcitonin gene-related peptide on angiotensin II-induced proliferation of rat vascular smooth muscle cells. , 2004, European journal of pharmacology.
[30] J. Olesen,et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. , 2004, The New England journal of medicine.
[31] A. Zalewski,et al. Increased NAD(P)H Oxidase and Reactive Oxygen Species in Coronary Arteries After Balloon Injury , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[32] J. Sanes,et al. Mice Lacking α-Calcitonin Gene-Related Peptide Exhibit Normal Cardiovascular Regulation and Neuromuscular Development , 1999, Molecular and Cellular Neuroscience.
[33] J. Changeux,et al. Modulation of morphine analgesia in αcgrp mutant mice , 1999 .
[34] Melanie G. Lee,et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor , 1998, Nature.
[35] P. Brecher,et al. Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. , 1998, Circulation research.
[36] A. Fujimori,et al. Enhanced Depressor and Hyperemic Responses to Calcitonin Gene-related Peptide in Spontaneously Hypertensive Rats , 1998, Peptides.
[37] X. Wang,et al. The antiproliferative effects of calcitonin gene-related peptide in different passages of cultured vascular smooth muscle cells , 1997, Neuropeptides.
[38] D. DiPette,et al. Regulation of neuronal calcitonin gene-related peptide expression. Role of increased blood pressure. , 1995, Hypertension.
[39] F. Portaluppi,et al. Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man. , 1993, The Journal of clinical endocrinology and metabolism.
[40] H. Kishimoto,et al. The antihypertensive effect of calcitonin gene-related peptide in rats with norepinephrine- and angiotensin II-induced hypertension. , 1991, Journal of Hypertension.
[41] A. Haegerstrand,et al. Calcitonin gene-related peptide stimulates proliferation of human endothelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[42] T. Längle,et al. Plasma CGRP in acute myocardial infarction , 1990, The Lancet.
[43] H. Morris,et al. Calcitonin gene-related peptide is a potent vasodilator , 1985, Nature.
[44] M. Mulvany,et al. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. , 1977, Circulation research.
[45] Tamara,et al. NADPH Oxidases, Reactive Oxygen Species, and Hypertension Clinical implications and therapeutic possibilities , 2008 .
[46] D. Harrison,et al. Angiotensin II-induced hypertrophy is potentiated in mice overexpressing p22phox in vascular smooth muscle. , 2005, American journal of physiology. Heart and circulatory physiology.
[47] K. Westlund,et al. Increased blood pressure in alpha-calcitonin gene-related peptide/calcitonin gene knockout mice. , 2000, Hypertension.
[48] K. Westlund,et al. Increased Blood Pressure in α-Calcitonin Gene–Related Peptide/Calcitonin Gene Knockout Mice , 2000 .
[49] J. Changeux,et al. Modulation of morphine analgesia in alphaCGRP mutant mice. , 1999, Neuroreport.